Prices delayed by at least 15 minutes | Print
Gabather AB (GABA)
Open
2.39 SEK
Previous close
2.39 SEK
Trade high
2.5 SEK
Volume
17,525
Year high
8.22 SEK
Year low
0.79 SEK
Dividend yield
-
Market capitalisation
39.99 mn SEK
P/E ratio
38.46
ISIN
SE0010869552
This share can be held in a Dealing accountSIPP
Share price
Company profile
Gabather AB is engaged in developing novel drugs to treat several diseases originating in the central nervous system. It has four main focus areas anti-psychotics, anti-depressants and anxiolytics, analgesics, as well as cognition-enhancing treatments, including for Alzheimer's disease.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.